FBXW7 and prostate carcinoma: Fbxw7 has been characterized as a general tumor suppressor in human cancer, and reduced Fbxw7 expression is often observed in multiple human cancers, including breast cancer, colorectal cancer, gastric cancer, prostate cancer, pancreatic cancer and hepatocellular carcinoma [17].